Cg. Elliott et al., PHYSICIAN-GUIDED TREATMENT COMPARED WITH A HEPARIN PROTOCOL FOR DEEP-VEIN THROMBOSIS, Archives of internal medicine, 154(9), 1994, pp. 999-1004
Background: Effective heparin therapy, defined by therapeutic prolonga
tion of the activated partial thromboplastin time (APTT), decreases th
e risk of recurrent venous thromboembolism. Achieving therapeutic prol
ongation of the APTT within 24 hours of the start of heparin therapy h
as proved difficult. We hypothesized that a protocol that delivered hi
gh initial heparin infusions to patients without identifiable risk for
bleeding complications would decrease the time to achieve a therapeut
ic anticoagulant effect without increasing the incidence of major blee
ding complications. Methods: To test this hypothesis, we studied concu
rrent patient cohorts. We defined a therapeutic anticoagulant effect (
APTT > 55 seconds) to be an APTT more than 1.5 times the upper limit o
f normal. Twenty patients with acute symptomatic deep vein thrombosis
received a 5000-U heparin bolus, followed by 1680 U/h (low risk to ble
ed) or 1240 U/h (high risk to bleed), adjusted by protocol-directed re
sponse to APTT results. Forty-eight patients with deep vein thrombosis
were treated by their physicians. The Kaplan-Meier method was used to
examine the proportion of patients who achieved an APTT greater than
55 seconds as a function of time. Results: The two study cohorts did n
ot differ with respect to age, weight, or risk factors for venous thro
mboembolism. Analysis of Kaplan-Meier curves showed that the heparin p
rotocol decreased the time to achieve a therapeutic anticoagulant effe
ct (P = .025). Ten (91%) of 11 patients (95% confidence interval, 59%
to 100%) without risks to bleed who were treated by the heparin protoc
ol and 29 (60%) of 48 patients (95% confidence interval, 45% to 74%) n
ot treated by the protocol had an initial therapeutic APTT (P = .006).
Conclusion: A protocol that delivers higher initial heparin infusions
to patients without identifiable risks for bleeding decreases the tim
e needed to achieve therapeutic prolongation of APTT, when compared wi
th nonprotocol physician management.